mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.05 |
mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.05 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.05 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |
mRNA |
VER-155008 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.05 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.05 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.05 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.06 |
mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.06 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.06 |